Global Antihypertensive Drugs Market Analysis & Forecast from 2019 to 2027 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Antihypertensive Drugs Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 – 2027” report has been added to ResearchAndMarkets.com’s offering.

Antihypertensive Drugs Market – Scope of the Report

This report on the global antihypertensive drugs market studies the past as well as current growth trends and opportunities to gain valuable insights of the same indicators for the said market during the forecast period from 2019 to 2027. The report provides the overall market revenue of the antihypertensive drugs market for the period of 2017-2027, with 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the antihypertensive drugs market for the forecast period.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the antihypertensive drugs market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the antihypertensive drugs market. The next section of the antihypertensive drugs report highlights the USPs, which include regulatory scenario, reimbursement scenario, key mergers & acquisitions, technological advancements, and key industry developments in the antihypertensive drugs market.

The report delves into the competitive landscape of the antihypertensive drugs market. Key players operating in the antihypertensive drugs market have been identified, and each one of them has been profiled for their distinguishing business attributes. Company overview, financial standings, recent developments, and SWOTs are some of the attributes of players in the antihypertensive drugs market profiled in this report.

Key Questions Answered

• What are the major drivers, restraints, and opportunities in the market?
• What will be the revenue share projections of key segments in the antihypertensive drugs market during the forecast period?
• Which segment is likely to lead the antihypertensive drugs market in terms of revenue by 2027?
• How mergers & acquisitions among players are widening the scope for antihypertensive drugs market?
• What are the market positions of different companies operating in the global antihypertensive drugs market?

Key Topics Covered:

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Antihypertensive Drugs Market

4. Market Overview

4.1. Introduction

4.2. Overview

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

4.4. Global Antihypertensive Drugs Market Analysis and Forecast, 2017-2027

4.4.1. Market Revenue Projections (US$ Mn)

5. Market Outlook

5.1. Key Industry Developments

5.2. Regulatory Scenario

5.3. Reimbursement Scenario

5.4. Key Mergers & Acquisitions

5.5. Technological Advancements

6. Global Antihypertensive Drugs Market Value (US$ Mn) Forecast, by Drug

6.1. Introduction & Definition

6.2. Global Antihypertensive Drugs Market Value Forecast, by Drug, 2017-2027

6.2.1. Diuretics

6.2.2. Angiotensin Converting Enzyme Inhibitors

6.2.3. Angiotensin Receptor Blockers

6.2.4. Beta-blockers

6.2.4.1. Beta-1 Selective

6.2.4.2. Intrinsic Sympathomimetic

6.2.5. Vasodilators

6.2.6. Calcium Channel Blockers

6.2.7. Renin Inhibitors

6.2.8. Alpha-blockers

6.2.9. Others

6.3. Global Antihypertensive Drugs Market Attractiveness, by Drug

7. Global Antihypertensive Drugs Market Value (US$ Mn) Forecast, by Condition

7.1. Introduction & Definition

7.2. Global Antihypertensive Drugs Market Value Forecast, by Condition, 2017-2027

7.2.1. Primary Hypertension

7.2.2. Secondary Hypertension

7.3. Global Antihypertensive Drugs Market Attractiveness, by Condition

8. Global Antihypertensive Drugs Market Value (US$ Mn) Forecast, by Medication Type

8.1. Introduction

8.2. Global Antihypertensive Drugs Market Value Forecast, by Medication Type, 2017-2027

8.2.1. Monotherapy

8.2.2. Combination Therapy

8.2.3. Fixed Dose Combinations

8.3. Global Antihypertensive Drugs Market Attractiveness, by Medication Type

9. Global Antihypertensive Drugs Market Value (US$ Mn) Forecast, by Distribution Channel

9.1. Introduction

9.2. Global Antihypertensive Drugs Market Value Forecast, by Distribution Channel, 2017-2027

9.2.1. Retail Pharmacies

9.2.2. Hospital Pharmacies

9.2.3. Online Pharmacies

9.2.4. Others

9.3. Global Antihypertensive Drugs Market Attractiveness, by Distribution Channel

10. Global Antihypertensive Drugs Market Value (US$ Mn) Forecast, by Region

10.1. Introduction

10.2. Antihypertensive Drugs Market Value Forecast, by Region, 2017-2027

10.3. Global Antihypertensive Drugs Market Attractiveness, by Region

11. North America Antihypertensive Drugs Market Analysis and Forecast

11.1. Introduction

11.2. North America Antihypertensive Drugs Market Value Forecast, by Drug, 2017-2027

11.3. North America Antihypertensive Drugs Market Value Forecast, by Condition, 2017-2027

11.4. North America Antihypertensive Drugs Market Value Forecast, by Medication Type, 2017-2027

11.5. North America Antihypertensive Drugs Market Value Forecast, by Distribution Channel, 2017-2027

11.6. North America Antihypertensive Drugs Market Value Forecast, by Country, 2017-2027

11.7. North America Antihypertensive Drugs Market Attractiveness Analysis

12. Europe Antihypertensive Drugs Market Analysis and Forecast

13. Asia Pacific Antihypertensive Drugs Market Analysis and Forecast

14. Latin America Antihypertensive Drugs Market Analysis and Forecast

15. Middle East & Africa Antihypertensive Drugs Market Analysis and Forecast

16. Competition Landscape

16.1. Global Antihypertensive Drugs Market Share Analysis, by Company (2018)

16.2. Company Profiles

16.2.1. Pfizer Inc.

16.2.2. Sanofi S.A

16.2.3. Novartis AG

16.2.4. Boehringer Ingelheim GmbH

16.2.5. Actelion Ltd.

16.2.6. F. Hoffmann-La Roche Ltd.

16.2.7. Bayer AG

16.2.8. Daiichi Sankyo Company, Limited

16.2.9. Takeda Pharmaceutical Company Limited

For more information about this report visit https://www.researchandmarkets.com/r/uzivp6

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900